GL1X · GenesisL1 explorer

Research workbench

Structure of influenza B PB2 cap-binding domain with Q325F mutation complex with GDP

Analyse Structure of influenza B PB2 cap-binding domain with Q325F mutation complex… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4OR6
Type
protein
Length
325 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Polymerase basic protein 2
Ligands
GDP
Pockets
3 · best druggability 0.37

Structure

x-ray diffraction · 2 distinct chains · 23% helix, 42% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APolymerase basic protein 2protein16323% helix, 42% strand—
BPolymerase basic protein 2protein16223% helix, 41% strand—

Ligands and binding sites

  • GDP · Guanosine-5'-diphosphate · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1880.370.7518GDP
2890.370.7518GDP
3680.300.7415empty

Interfaces

1 interface between chains.

  • A–B · 416 Ų buried · 5 hydrogen bonds · protein-protein

Compared structures

  • 4OR6 · Structure of Influenza B PB2 cap-binding domain with Q325F mutation complex with GDP · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.